Nuedexta 20-10 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F88PA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,853
Award facts
- Contract value 100% obligated
- $12,853.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,853.42 to AmerisourceBergen Drug Corp for the supply of Nuedexta 20-10 mg capsules (60-count units) on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which does business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains for the Department of Defense and related federal health systems. This delivery order for Nuedexta, a neurological treatment medication, exemplifies the company's ongoing role in supplying specialized pharmaceutical products to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F88PA?
SPE2DR26F88PA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F88PA worth?
The government has obligated $12,853 on SPE2DR26F88PA.
Is contract SPE2DR26F88PA an order under another contract?
Yes. SPE2DR26F88PA is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88PA competed?
The extent of competition for SPE2DR26F88PA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award